Ken Declerck Selected Research

Ken Declerck Research Topics

Disease

5	Neoplasms (Cancer) 01/2021 - 01/2014
4	Atherosclerosis 01/2019 - 01/2016
3	Breast Neoplasms (Breast Cancer) 05/2022 - 01/2014
3	Neoplasm Metastasis (Metastasis) 01/2021 - 01/2014
3	Inflammation (Inflammations) 01/2020 - 10/2018
2	Colorectal Neoplasms (Colorectal Cancer) 01/2021 - 01/2021
2	Stroke (Strokes) 01/2019 - 08/2017
2	Cardiovascular Diseases (Cardiovascular Disease) 11/2017 - 01/2016
2	Triple Negative Breast Neoplasms 06/2017 - 01/2014
1	Common Cold 05/2021
1	Severe Acute Respiratory Syndrome 05/2021
1	Infections 05/2021
1	Multiple Myeloma 03/2021
1	Carcinoma (Carcinomatosis) 01/2021
1	Sotos Syndrome 12/2020
1	Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (T-ALL) 11/2020
1	Melanoma (Melanoma, Malignant) 01/2020
1	Hypertension (High Blood Pressure) 01/2020
1	Alzheimer Disease (Alzheimer's Disease) 01/2019
1	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 01/2019
1	Disease Susceptibility (Diathesis) 01/2018
1	Neuroblastoma 01/2018
1	Brain Ischemia (Cerebral Ischemia) 08/2017
1	Ischemia 08/2017
1	Metabolic Diseases (Metabolic Disease) 01/2017
1	Diabetes Mellitus 01/2017

Drug/Important Bio-Agent (IBA)

4	Biomarkers (Surrogate Marker)IBA 05/2022 - 11/2017
4	withaferin AIBA 03/2021 - 01/2014
4	DNA (Deoxyribonucleic Acid)IBA 11/2020 - 01/2016
2	mangiferinIBA 01/2021 - 01/2020
2	A-Form DNA (A-DNA)IBA 12/2020 - 06/2017
2	Decitabine FDA Link 11/2020 - 06/2017
2	Catechin (Z 7300)IBA 01/2020 - 10/2018
2	Interleukin-6 (Interleukin 6)IBA 01/2020 - 01/2014
2	Urokinase-Type Plasminogen Activator (Urokinase)FDA Link 01/2020 - 06/2017
2	Metalloproteases (Metalloproteinases)IBA 01/2020 - 06/2017
2	Proteins (Proteins, Gene)FDA Link 01/2019 - 01/2016
2	Estrogen ReceptorsIBA 11/2017 - 06/2017
1	InterferonsIBA 05/2021
1	Antiviral Agents (Antivirals)IBA 05/2021
1	Agammaglobulinaemia Tyrosine KinaseIBA 03/2021
1	Cysteine (L-Cysteine)FDA Link 03/2021
1	GlucocorticoidsIBA 03/2021
1	PolyphenolsIBA 01/2021
1	Fatty Acids (Saturated Fatty Acids)IBA 01/2021
1	Oxidoreductases (Dehydrogenase)IBA 01/2021
1	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 01/2021
1	SirtuinsIBA 01/2021
1	gamma-Aminobutyric Acid (GABA)IBA 01/2020
1	LipidsIBA 01/2020
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2020
1	Plasminogen Activators (Plasminogen Activator)IBA 01/2020
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2020
1	LigandsIBA 01/2020
1	ReninIBA 01/2020
1	ChemokinesIBA 01/2020
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2020
1	Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA 01/2020
1	Interferon-gamma (Interferon, gamma)IBA 01/2020
1	AngiotensinsIBA 01/2020
1	NeuroglobinIBA 01/2019
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2019
1	Cytochromes c (Cytochrome c)IBA 01/2019
1	Etoposide (VP 16)FDA LinkGeneric 01/2018
1	Cisplatin (Platino)FDA LinkGeneric 01/2018
1	CalciumIBA 11/2017
1	RNA (Ribonucleic Acid)IBA 08/2017
1	Transcription Factors (Transcription Factor)IBA 08/2017
1	Neuroprotective AgentsIBA 08/2017
1	Protein Kinases (Protein Kinase)IBA 06/2017
1	Glutathione Transferase (Glutathione S-Transferase)IBA 06/2017
1	tyrosine receptor (receptor, tyrosine)IBA 06/2017
1	Cytokine TWEAKIBA 06/2017
1	Progesterone Receptors (Progesterone Receptor)IBA 06/2017
1	LactonesIBA 06/2017
1	EnzymesIBA 06/2017
1	Phenobarbital (Luminal)FDA Link 06/2017
1	NeuregulinsIBA 01/2017
1	Hormones (Hormone)IBA 01/2017
1	PesticidesIBA 01/2017
1	Adrenocorticotropic Hormone (ACTH)FDA Link 01/2017
1	dipalmitoylphosphatidylserineIBA 02/2016
1	Dipeptidyl-Peptidases and Tripeptidyl-PeptidasesIBA 02/2016
1	MicroRNAs (MicroRNA)IBA 01/2016
1	ChromatinIBA 01/2016
1	IntegrinsIBA 01/2014
1	Cell Adhesion MoleculesIBA 01/2014
1	withanoneIBA 01/2014
1	Peptide Hydrolases (Proteases)FDA Link 01/2014
1	PhytochemicalsIBA 01/2014
1	AshwagandhaIBA 01/2014

Therapy/Procedure

3	Therapeutics 01/2021 - 01/2014
1	Immunomodulation 05/2021